title: Effect of quercetin on metallothionein, nitric oxide synthases and cyclooxygenase-2 expression on experimental chronic cadmium nephrotoxicity in rats.
abstract: Inflammation can play a key role in Cd-induced dysfunctions. Quercetin is a potent oxygen free radical scavenger and a metal chelator. Our aim was to study the effect of quercetin on Cd-induced kidney damage and metallothionein expression. The study was performed in Wistar rats that were administered during 9 weeks with either cadmium (1.2 mg Cd/kg/day, s.c.), quercetin (50 mg/kg/day, i.p.) or cadmium + quercetin. Renal toxicity was evaluated by measuring blood urea nitrogen concentration and urinary excretion of enzymes marker of tubular damage. Endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) renal expression were assessed by Western blot. Renal expression of metallothionein 1 and 2 (MT-1, MT-2) and eNOS mRNA was assessed by Northern blot. Our data demonstrated that Cd-induced renal toxicity was markedly reduced in rats that also received quercetin. MT-1 and MT-2 mRNA levels in kidney were substantially increased during treatment with Cd, being even higher when the animals received Cd and quercetin. Renal eNOS expression was significantly higher in rats receiving Cd and quercetin than in animals receiving Cd alone or in control rats. In the group that received Cd, COX-2 and iNOS expression was markedly higher than in control rats. In the group Cd+quercetin, no changes in COX-2 and iNOS expression were observed compared with the control group. Our results demonstrate that quercetin treatment prevents Cd-induced overexpression of iNOS and COX-2, and increases MT expression. These effects can explain the protection by quercetin of Cd-induced nephrotoxicity.
authors.affiliation: Instituto Reina Sofía de Investigación Nefrológica, Departamento de Fisiología y Farmacología, Edificio Departamental, Campus Miguel de Unamuno, 37007 Salamanca, Spain.
authors.forename: Ana I
authors.initials: AI
authors.lastname: Morales
authors.forename: César
authors.initials: C
authors.lastname: Vicente-Sánchez
authors.forename: Mirjana
authors.initials: M
authors.lastname: Jerkic
authors.forename: José M
authors.initials: JM
authors.lastname: Santiago
authors.forename: Penélope D
authors.initials: PD
authors.lastname: Sánchez-González
authors.forename: Fernando
authors.initials: F
authors.lastname: Pérez-Barriocanal
authors.forename: José M
authors.initials: JM
authors.lastname: López-Novoa
mesh_terms: D000818:Animals; D019187:Cadmium Compounds / Q000633:toxicity*; D002908:Chronic Disease; D051546:Cyclooxygenase 2 / Q000096:biosynthesis*; D004195:Disease Models, Animal; D004790:Enzyme Induction; D007674:Kidney Diseases / Q000139:chemically induced* / Q000201:enzymology / Q000378:metabolism / Q000517:prevention & control; D008297:Male; D008668:Metallothionein / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D020011:Protective Agents / Q000627:therapeutic use*; D011794:Quercetin / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D019187:Cadmium Compounds; D020011:Protective Agents; D008668:Metallothionein; D011794:Quercetin; D019001:Nitric Oxide Synthase; D051546:Cyclooxygenase 2